Green Market Report's Marijuana Money November 8, 2019

Earnings season is underway and with the sector in a bear market, there seems to be a lot of pressure on companies to deliver solid results. GW Pharmaceuticals managed to do that but the stock still tumbled confusing shareholders. The company reported third-quarter net sales of $86 million in the cannabis drug Epidiolex. Revenue for the quarter was $91 million beating estimates. The losses were cut to $13 million versus last year’s $79 million, still, the stock sold off.

Innovative Industrial Properties beat analyst estimates with revenue that rose over 200% to $11 million and earnings per share of 55 cents. The dividend increased by 30% to 78 cents per share. The stock jumped over 9% on the news. 

CV Sciences (OTCQB:CVSI) reported revenue of $12.6M (-7.4% Y/Y) which missed estimates by $6.01M. Third-quarter sales were impacted by increased market competition in the natural product category, and the continued impacts on retail customers as a result of the uncertain regulatory environment for CBD. The third quarter Non-GAAP EPS of -$0.01 missed by $0.02 and the GAAP EPS of -$0.02 missed by $0.03. The decline in operating income is primarily related to reduced sales and additional investment in sales, marketing, and R&D activities.

For fiscal year 2019, the company expects revenue to be in the range of $55 million to $57 million.

Merida Priced its IPO to form a $120 million special purchase acquisition company. The units will commence trading November 5, 2019 on Nasdaq under the symbol “MCMJU” and are expected to commence trading on the Neo Exchange Inc. on or about November 8, subject to satisfying certain listing conditions, under the symbol “MMK.UN”.

TILT Holdings closed on a $35 million private placement which will be used to pay off a high-interest rate bridge loan. The company also agreed to board changes.

Terra Tech is merging with the over the counter drug company OneQor and may spin off its cannabis holdings.

Sunniva lost its CFO but said its CannaPharmRx deal is still on.

MediPharm Labs filed to list on the NASDAQ.

Video Staff

Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.


We respect your privacy. See our privacy policy.

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

@GreenMarketRpt – 4 hours

Jazz Pharmaceuticals MS Study Misses Its Mark

@GreenMarketRpt – 5 hours

Analysts Are Warming Up To Aurora Cannabis

@GreenMarketRpt – 6 hours

Aleafia Health Reaffirms Guidance For 2023

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.


We respect your privacy. See our privacy policy.